Perceptive Advisors – GLOBAL BLOOD THERAPEUTICS IN

Perceptive Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
QuarterValueSharesWeighting
Q1 2021$412,278
67.7%
10,117,284
78.3%
2.60%
-1.3%
Q4 2020$245,771
-23.2%
5,674,711
-2.2%
2.64%
-43.5%
Q3 2020$319,867
-13.3%
5,800,996
-0.7%
4.67%
-21.9%
Q2 2020$368,811
19.0%
5,842,100
-3.7%
5.98%
-26.0%
Q1 2020$309,897
-33.5%
6,065,726
3.4%
8.07%
-12.9%
Q4 2019$466,266
63.6%
5,865,726
-0.2%
9.26%
20.6%
Q3 2019$285,090
-6.2%
5,875,726
1.7%
7.68%
10.2%
Q2 2019$303,803
3.9%
5,775,726
4.5%
6.97%
-15.5%
Q1 2019$292,476
31.3%
5,525,726
1.8%
8.25%
-2.6%
Q4 2018$222,726
13.8%
5,425,726
5.4%
8.48%
62.0%
Q3 2018$195,658
-10.4%
5,148,910
6.6%
5.23%
-8.6%
Q2 2018$218,266
-9.4%
4,828,910
-3.2%
5.72%
-15.2%
Q1 2018$240,971
25.3%
4,989,066
2.0%
6.75%
5.8%
Q4 2017$192,384
-27.3%
4,889,066
-42.7%
6.38%
26.1%
Q3 2017$264,798
146.1%
8,528,132
116.8%
5.06%
-6.6%
Q2 2017$107,592
-24.3%
3,933,927
1.9%
5.41%
-33.2%
Q1 2017$142,203
214.5%
3,858,978
23.3%
8.10%
152.0%
Q4 2016$45,213
-16.0%
3,128,978
34.1%
3.22%
-7.4%
Q3 2016$53,802
46.9%
2,334,168
5.7%
3.47%
36.8%
Q2 2016$36,625
78.0%
2,207,668
70.2%
2.54%
40.7%
Q1 2016$20,577
-46.4%
1,297,468
9.3%
1.80%
-36.4%
Q4 2015$38,363
-50.6%
1,186,630
-35.6%
2.84%
-8.6%
Q3 2015$77,7261,843,6003.10%